Purpose To assess how the molecular biomarker status of a breast cancer, including human
epidermal growth factor receptor 2 (HER2), hormone receptors, and the proliferation marker …

Magnetic resonance imaging (MRI) has been proposed to have a role in predicting final
pathologic response when undertaken early during neoadjuvant chemotherapy (NAC) in …

Background A discrepancy often exists between the post-neoadjuvant chemotherapy (NAC)
breast tumor size on magnetic resonance imaging (MRI) and pathologic tumor size. We seek …

Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

OBJECTIVE. Our study investigated the usefulness of contrast-enhanced MR imaging for
accurately measuring the size of residual tumor after patients have undergone neoadjuvant …

This meta-analysis aimed to estimate and compare sensitivity, specificity, positive-(PPV) and
negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting …

The accuracy of mammography, sonography and magnetic resonance imaging (MRI) in
identifying residual disease after neoadjuvant chemotherapy is evaluated and imaging …

Purpose To prospectively compare the performance of dynamic contrast material–enhanced
(DCE) magnetic resonance (MR) imaging using parametric response map (PRM) analysis …

Background Patients with early breast cancer (EBC) achieving pathologic complete
response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis …

AIM: To assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual
disease after neoadjuvant chemotherapy in patients with large breast cancers. MATERIALS …